Literature DB >> 2889386

Further biochemical characterization of chronic Trypanosoma brucei gambiense-Microtus montanus infection.

J R Seed1, J Sechelski, J E Hall.   

Abstract

Tyrosine aminotransferase (TAT), glutamic-pyruvic transaminase (GPT), glutamic-oxaloacetic transaminase (GOT), and alkaline phosphatase (ALP) were measured in the serum and livers of Microtus montanus infected with Trypanosoma brucei gambiense. Only liver TAT and serum ALP showed significant changes. In addition, blood glucose, pyruvate and lactate, and liver glycogen levels were assayed. All four compounds showed significant changes, strongly suggesting increased glycogen mobilization and increased catabolic activity. Interestingly, the serum ketone levels were very low and no significant changes were observed. These chronically infected animals had an organic aciduria in which pyruvate, lactate, beta-hydroxybutyrate, alpha-ketoglutarate, phenylpyruvate, and p-hydroxyphenylpyruvate were significantly increased. The possible significance of these observations is discussed.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2889386     DOI: 10.4269/ajtmh.1987.37.314

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  2 in total

1.  Metabolomics guides rational development of a simplified cell culture medium for drug screening against Trypanosoma brucei.

Authors:  Darren J Creek; Brunda Nijagal; Dong-Hyun Kim; Federico Rojas; Keith R Matthews; Michael P Barrett
Journal:  Antimicrob Agents Chemother       Date:  2013-04-09       Impact factor: 5.191

2.  Revisiting the central metabolism of the bloodstream forms of Trypanosoma brucei: production of acetate in the mitochondrion is essential for parasite viability.

Authors:  Muriel Mazet; Pauline Morand; Marc Biran; Guillaume Bouyssou; Pierrette Courtois; Sylvie Daulouède; Yoann Millerioux; Jean-Michel Franconi; Philippe Vincendeau; Patrick Moreau; Frédéric Bringaud
Journal:  PLoS Negl Trop Dis       Date:  2013-12-19
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.